ERP29 and cancer: Future studies should aim to further elucidate ERp29’s role in UPR, as this response plays a key role in the underlying pathophysiology of cancer and many other diseases, including those of secretory cells such as the insulin-secreting β-cells in Type II diabetes (Ozcan et al., 2004; Sundar Rajan et al., 2007).